Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Pharmaceutical Statistics
|
May 9, 2025
Statistical Tutorial for Cut-Point Determination in Immunogenicity Studies
Yulia Mordashova, Xin Huang
Toxicologic Pathology
|
February 4, 2016
Quantification of Hepcidin-related Iron Accumulation in the Rat Liver
Preethne Böser, Yulia Mordashova, Mark Maasland, et al.
Acta Neuropathologica Communications
|
November 15, 2019
N368-Tau fragments generated by legumain are detected only in trace amount in the insoluble Tau aggregates isolated from AD brain
Kerstin Schlegel, Khader Awwad, Roland G Heym, et al.
Neurobiology of Aging
|
October 16, 2021
Tau in the brain interstitial fluid is fragmented and seeding-competent
Erica Barini, Gudrun Plotzky, Yulia Mordashova, et al.
Translational Stroke Research
|
June 16, 2023
Neutralizing RGMa with Elezanumab Promotes Cerebroprotection and Recovery in Rabbit Middle Cerebral Artery Occlusion
Peer B Jacobson, Andrea Mothe, Aharon Levy, et al.
Neurobiology of Disease
|
May 15, 2021
Elezanumab, a human anti-RGMa monoclonal antibody, promotes neuroprotection, neuroplasticity, and neurorecovery following a thoracic hemicompression spinal cord injury in non-human primates
Peer B Jacobson, Robin Goody, Matthew Lawrence, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 1, 2024
Head-to-head comparison of leading blood tests for Alzheimer's disease pathology
Suzanne E Schindler, Kellen K Petersen, Benjamin Saef, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 12, 2024
Head-to-head comparison of leading blood tests for Alzheimer's disease pathology
Suzanne E Schindler, Kellen K Petersen, Benjamin Saef, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 22, 2024
Timing of changes in Alzheimer's disease plasma biomarkers as assessed by amyloid and tau PET clocks
Marta Milà-Alomà, Duygu Tosun, Suzanne E Schindler, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 12, 2022
Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivity
Stephen Zicha, Randall J Bateman, Leslie M Shaw, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Pharmaceutical Statistics
|
May 9, 2025
Statistical Tutorial for Cut-Point Determination in Immunogenicity Studies
Yulia Mordashova, Xin Huang
Toxicologic Pathology
|
February 4, 2016
Quantification of Hepcidin-related Iron Accumulation in the Rat Liver
Preethne Böser, Yulia Mordashova, Mark Maasland, et al.
Acta Neuropathologica Communications
|
November 15, 2019
N368-Tau fragments generated by legumain are detected only in trace amount in the insoluble Tau aggregates isolated from AD brain
Kerstin Schlegel, Khader Awwad, Roland G Heym, et al.
Neurobiology of Aging
|
October 16, 2021
Tau in the brain interstitial fluid is fragmented and seeding-competent
Erica Barini, Gudrun Plotzky, Yulia Mordashova, et al.
Translational Stroke Research
|
June 16, 2023
Neutralizing RGMa with Elezanumab Promotes Cerebroprotection and Recovery in Rabbit Middle Cerebral Artery Occlusion
Peer B Jacobson, Andrea Mothe, Aharon Levy, et al.
Neurobiology of Disease
|
May 15, 2021
Elezanumab, a human anti-RGMa monoclonal antibody, promotes neuroprotection, neuroplasticity, and neurorecovery following a thoracic hemicompression spinal cord injury in non-human primates
Peer B Jacobson, Robin Goody, Matthew Lawrence, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 1, 2024
Head-to-head comparison of leading blood tests for Alzheimer's disease pathology
Suzanne E Schindler, Kellen K Petersen, Benjamin Saef, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 12, 2024
Head-to-head comparison of leading blood tests for Alzheimer's disease pathology
Suzanne E Schindler, Kellen K Petersen, Benjamin Saef, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 22, 2024
Timing of changes in Alzheimer's disease plasma biomarkers as assessed by amyloid and tau PET clocks
Marta Milà-Alomà, Duygu Tosun, Suzanne E Schindler, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 12, 2022
Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivity
Stephen Zicha, Randall J Bateman, Leslie M Shaw, et al.
Page
of 2